MJ

Meghal Jain

Active Director Designated Partner DIN 07899099
DIN 07899099 First appointment Aug 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Meghal Jain

Data last updated:

Meghal Jain is a Designated Partner at Milton Pharma Llp (since 2017). The company operates in Pharma. Milton Pharma Llp reported revenue of ₹26.36 Cr (FY 2023).

DIN 07899099
Primary Designation Designated Partner
Industry Pharma
First Appointment 18 Aug 2017
Oldest Company Age 9 yrs
Largest company Milton Pharma Llp · ₹26.36 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Aug 20172017₹26.36 Cr (FY 2023)Active

Board colleagues of Meghal Jain

NameDINCompanyDesignation
Akshay Anil Jain02599554Milton Pharma LlpDesignated Partner
Anil Chhaganlal Jain02035816Milton Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Milton Pharma Llp
Premium access

Shareholding and investment profile for Meghal Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meghal Jain

Meghal Jain currently holds 1 directorship: Milton Pharma Llp (Designated Partner, since 18 Aug 2017, revenue ₹26.36 Cr (FY 2023)).

Meghal Jain was first appointed on 18 Aug 2017 as Designated Partner at Milton Pharma Llp.

The current boards of Meghal Jain's companies include Akshay Anil Jain (Milton Pharma Llp), Anil Chhaganlal Jain (Milton Pharma Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available